drugset / Trial / NCT06800404
"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"
NaSingle-groupOpen-labelTreatment
Summary
This protocol is part of a clinical study to evaluate efficacy and safety of multiple intravenous administrations of HB-adMSCs for the treatment of Multiple Sclerosis.
Timeline
- Start
- 2025-05-02
- Primary completion
- 2027-01
- Completion
- 2027-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HB-adMSCs | Cell therapy | — | — |